Novartis (NVSN) Ratios
Novartis Ratios
MX:NVSN's free cash flow for Q3 2026 was $4.76B. For the 2026 fiscal year, MX:NVSN's free cash flow was decreased by $-742.00M and operating cash flow was $5.50B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.12 | 1.04 | 1.16 | 1.29 | 1.51 |
| Quick Ratio | 0.89 | 0.84 | 0.93 | 1.04 | 1.29 |
| Cash Ratio | 0.42 | 0.40 | 0.51 | 0.26 | 0.41 |
| Solvency Ratio | 0.28 | 0.31 | 0.43 | 0.24 | 0.46 |
| Operating Cash Flow Ratio | 0.71 | 0.61 | 0.55 | 0.50 | 0.50 |
| Short-Term Operating Cash Flow Coverage | 3.33 | 2.18 | 2.38 | 2.42 | 2.42 |
| Net Current Asset Value | $ -38.56B | $ -28.42B | $ -22.71B | $ -21.12B | $ -18.25B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.31 | 0.26 | 0.24 | 0.24 |
| Debt-to-Equity Ratio | 0.80 | 0.71 | 0.56 | 0.47 | 0.46 |
| Debt-to-Capital Ratio | 0.45 | 0.42 | 0.36 | 0.32 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.39 | 0.33 | 0.28 | 0.25 | 0.25 |
| Financial Leverage Ratio | 2.51 | 2.32 | 2.14 | 1.98 | 1.95 |
| Debt Service Coverage Ratio | 2.95 | 2.08 | 2.54 | 2.02 | 4.11 |
| Interest Coverage Ratio | 14.38 | 14.03 | 11.15 | 9.52 | 11.11 |
| Debt to Market Cap | 0.13 | 0.15 | 0.12 | 0.14 | 0.16 |
| Interest Debt Per Share | 19.71 | 16.00 | 13.11 | 13.18 | 14.24 |
| Net Debt to EBITDA | 1.11 | 0.96 | 0.71 | 1.39 | 0.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.02% | 75.20% | 73.27% | 73.35% | 73.31% |
| EBIT Margin | 32.17% | 28.32% | 21.38% | 18.35% | 57.57% |
| EBITDA Margin | 41.94% | 40.05% | 39.12% | 33.78% | 70.30% |
| Operating Profit Margin | 31.15% | 28.12% | 20.94% | 18.28% | 22.87% |
| Pretax Profit Margin | 29.99% | 26.37% | 19.55% | 16.51% | 55.78% |
| Net Profit Margin | 25.64% | 23.09% | 31.83% | 16.00% | 54.63% |
| Continuous Operations Profit Margin | 25.61% | 23.08% | 18.37% | 13.92% | 52.09% |
| Net Income Per EBT | 85.52% | 87.54% | 162.78% | 96.91% | 97.92% |
| EBT Per EBIT | 96.26% | 93.78% | 93.39% | 90.32% | 243.93% |
| Return on Assets (ROA) | 12.16% | 11.68% | 14.86% | 5.92% | 18.23% |
| Return on Equity (ROE) | 30.47% | 27.11% | 31.82% | 11.72% | 35.51% |
| Return on Capital Employed (ROCE) | 19.34% | 19.77% | 13.28% | 8.95% | 9.90% |
| Return on Invested Capital (ROIC) | 15.50% | 15.55% | 11.49% | 7.06% | 8.69% |
| Return on Tangible Assets | 23.20% | 23.61% | 29.86% | 12.31% | 35.32% |
| Earnings Yield | 5.26% | 6.08% | 7.08% | 3.71% | 12.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.01 | 6.30 | 4.98 | 4.39 | 4.57 |
| Payables Turnover | 3.07 | 2.81 | 2.53 | 2.25 | 2.11 |
| Inventory Turnover | 2.18 | 2.24 | 2.11 | 1.61 | 1.76 |
| Fixed Asset Turnover | 4.44 | 4.76 | 4.27 | 3.56 | 3.36 |
| Asset Turnover | 0.47 | 0.51 | 0.47 | 0.37 | 0.33 |
| Working Capital Turnover Ratio | 26.14 | 20.27 | 7.56 | 3.66 | 7.25 |
| Cash Conversion Cycle | 121.15 | 90.70 | 102.23 | 147.04 | 114.48 |
| Days of Sales Outstanding | 72.81 | 57.94 | 73.34 | 83.09 | 79.86 |
| Days of Inventory Outstanding | 167.15 | 162.85 | 173.05 | 226.12 | 207.34 |
| Days of Payables Outstanding | 118.81 | 130.10 | 144.16 | 162.17 | 172.72 |
| Operating Cycle | 239.96 | 220.80 | 246.39 | 309.21 | 287.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 9.92 | 8.73 | 6.96 | 6.53 | 6.72 |
| Free Cash Flow Per Share | 9.12 | 6.84 | 5.64 | 5.50 | 5.58 |
| Dividend Paid and CapEx Coverage Ratio | 2.04 | 1.54 | 1.44 | 1.46 | 1.52 |
| Capital Expenditure Coverage Ratio | 12.37 | 4.62 | 5.25 | 6.36 | 5.90 |
| Operating Cash Flow Coverage Ratio | 0.52 | 0.56 | 0.55 | 0.51 | 0.49 |
| Operating Cash Flow to Sales Ratio | 0.35 | 0.34 | 0.31 | 0.33 | 0.34 |
| Free Cash Flow Yield | 6.62% | 7.03% | 5.58% | 6.41% | 6.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.02 | 16.44 | 14.12 | 26.92 | 7.73 |
| Price-to-Sales (P/S) Ratio | 4.88 | 3.80 | 4.49 | 4.31 | 4.22 |
| Price-to-Book (P/B) Ratio | 5.79 | 4.46 | 4.49 | 3.16 | 2.74 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 15.11 | 14.23 | 17.91 | 15.61 | 14.83 |
| Price-to-Operating Cash Flow Ratio | 13.89 | 11.15 | 14.50 | 13.15 | 12.32 |
| Price-to-Earnings Growth (PEG) Ratio | 0.85 | -0.96 | 0.11 | -0.38 | 0.04 |
| Enterprise Value Multiple | 12.74 | 10.44 | 12.20 | 14.14 | 6.61 |
| Enterprise Value | 292.92B | 216.20B | 222.65B | 207.65B | 204.24B |
| EV to EBITDA | 12.74 | 10.44 | 12.20 | 14.14 | 6.61 |
| EV to Sales | 5.34 | 4.18 | 4.77 | 4.78 | 4.64 |
| EV to Free Cash Flow | 16.56 | 15.66 | 19.02 | 17.31 | 16.32 |
| EV to Operating Cash Flow | 15.22 | 12.27 | 15.40 | 14.59 | 13.55 |
| Tangible Book Value Per Share | -4.35 | -3.74 | -1.67 | -0.70 | 1.80 |
| Shareholders’ Equity Per Share | 23.79 | 21.82 | 22.47 | 27.21 | 30.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.12 | 0.06 | 0.16 | 0.07 |
| Revenue Per Share | 28.27 | 25.63 | 22.47 | 19.93 | 19.61 |
| Net Income Per Share | 7.25 | 5.92 | 7.15 | 3.19 | 10.71 |
| Tax Burden | 0.86 | 0.88 | 1.63 | 0.97 | 0.98 |
| Interest Burden | 0.93 | 0.93 | 0.91 | 0.90 | 0.97 |
| Research & Development to Revenue | 0.20 | 0.19 | 0.24 | 0.21 | 0.20 |
| SG&A to Revenue | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 1.37 | 1.48 | 1.69 | 2.35 | 0.66 |
Currency in USD